Semler Scientific Inc
NASDAQ:SMLR
Operating Margin
Semler Scientific Inc
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Operating Margin Across Competitors
| Country | Company | Market Cap |
Operating Margin |
||
|---|---|---|---|---|---|
| US |
|
Semler Scientific Inc
NASDAQ:SMLR
|
375.8m USD |
26%
|
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
229.3B USD |
17%
|
|
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
182.6B USD |
28%
|
|
| US |
|
Boston Scientific Corp
NYSE:BSX
|
149.9B USD |
19%
|
|
| US |
|
Stryker Corp
NYSE:SYK
|
142.6B USD |
22%
|
|
| IE |
|
Medtronic PLC
NYSE:MDT
|
109.9B USD |
20%
|
|
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
52B EUR |
14%
|
|
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
48.3B USD |
13%
|
|
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
43.5B USD |
28%
|
|
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
42B USD |
29%
|
|
| CN |
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
274B CNY |
34%
|
Semler Scientific Inc
Glance View
Semler Scientific, Inc. engages in the provision of technology and software solutions to improve the clinical effectiveness of healthcare providers. The company is headquartered in Santa Clara, California and currently employs 124 full-time employees. The company went IPO on 2014-02-27. The firm develops, manufactures, and markets products and services that assist its customers in evaluating and treating chronic diseases. Its vascular testing product, QuantaFlo, measures arterial blood flow in the extremities to aid in the diagnosis of peripheral arterial disease (PAD). QuantaFlo is a four-minute in-office blood flow test. Healthcare providers can use blood flow measurements as part of their examinations of a patient's vascular condition, including assessments of patients who have vascular disease. The company also has a distribution arrangement for the United States, including Puerto Rico, to distribute Insulin Insights, a software solution designed to provide insulin dosing recommendations to clinicians for the adjustment and maintenance of blood. The firm's customers for QuantaFlo include insurance plans, physician groups, and risk assessment groups.
See Also
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Based on Semler Scientific Inc's most recent financial statements, the company has Operating Margin of 25.6%.
You don't have any saved screeners yet